Prediction of clinicopathological features, multi-omics events and prognosis based on digital pathology and deep learning in HR+/HER2− breast cancer
Jia Hu(Fudan University Shanghai Cancer Center), Guan-Hua Su(Fudan University Shanghai Cancer Center), Cai‐Jin Lin(Shanghai Medical College of Fudan University), Shen Zhao(Fudan University Shanghai Cancer Center), Hong Lv(Nanjing Maternity and Child Health Care Hospital)
Cited by 14
Related Papers
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
|Signal Transduction and Targeted Therapy|2021|171
Radiomics in breast cancer: Current advances and future directions
|Cell Reports Medicine|2024|143
Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
|Science Advances|2023|114
Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
|Cell Reports Medicine|2022|92